MedTrace Logo

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

NCT04975217 · Status: SUSPENDED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-05-22

No results posted yet for this study

Summary

This early phase I trial examines the safety and effects of fecal microbial transplants in treating patients with pancreatic cancer. scheduled for surgery to remove tumors. Fecal microbial transplant contains the normal microbes found in fecal (stool) material. Giving fecal microbial transplant may help control the disease.

Conditions

Interventions

PROCEDURE

Fecal Microbiota Transplantation

Undergo FMT

DRUG

Fecal Microbiota Transplantation Capsule

Given PO

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Resection

Undergo standard of care resection

PROCEDURE

Therapeutic Colonoscopy

Undergo colonoscopy

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Florencia McAllister, MD · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-14
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04975217 on ClinicalTrials.gov